ArticleReports of biochemistry & molecular biology2022

AMG-232, a New Inhibitor of MDM-2, Enhance Doxorubicin Efficiency in Pre-B Acute Lymphoblastic Leukemia Cells.

Abbas Ghotaslou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.